Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Poynard

Showing results (71-80 of 324) with videos related to

Pageof 33
Sort By:
La Revue Du Praticien|July 25, 2000
[Treatment and prevention of hepatitis C]T Poynard, V Ratziu, Y Benhamou, et al.
Lancet (London, England)|January 19, 1980
Pectin efficacy in insulin-treated diabetics assessed by the artificial pancreasT Poynard, G Slama, A Delage, et al.
Gastroenterologie Clinique Et Biologique|April 18, 2009
The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050-60: "Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests"M Munteanu, Y Ngo, V Ratziu, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Evaluation by a randomized trial of the usefulness of endoscopy after treatment of a flare-up of non-severe esophagitis]T Poynard, Y Ottignon, C Pauphilet, et al.
Digestive Diseases and Sciences|March 1, 1990
Endoscopic Nd-YAG laser therapy as palliative treatment for esophageal and cardial cancer. Parameters affecting long-term outcomeS Naveau, A Chiesa, T Poynard, et al.
The New England Journal of Medicine|December 3, 1981
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled studyD Lebrec, T Poynard, P Hillon, et al.
Hepatology (Baltimore, Md.)|April 27, 1999
Modeling the hepatitis C virus epidemic in FranceS Deuffic, L Buffat, T Poynard, et al.
Age and Ageing|July 1, 1994
A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjectsP Brocker, B Vellas, J L Albarede, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1994
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndromeT Poynard, S Naveau, B Mory, et al.
Gastroenterologie Clinique Et Biologique|June 1, 1986
Sensitivity, specificity and predictive values of the secretin infusion test in the diagnosis of gastrinomaT Poynard, M Mignon, J P Accary, et al.
Pageof 33

Showing results (71-80 of 324) with videos related to

Sort By:
Pageof 33
La Revue Du Praticien|July 25, 2000
[Treatment and prevention of hepatitis C]T Poynard, V Ratziu, Y Benhamou, et al.
Lancet (London, England)|January 19, 1980
Pectin efficacy in insulin-treated diabetics assessed by the artificial pancreasT Poynard, G Slama, A Delage, et al.
Gastroenterologie Clinique Et Biologique|April 18, 2009
The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050-60: "Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests"M Munteanu, Y Ngo, V Ratziu, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Evaluation by a randomized trial of the usefulness of endoscopy after treatment of a flare-up of non-severe esophagitis]T Poynard, Y Ottignon, C Pauphilet, et al.
Digestive Diseases and Sciences|March 1, 1990
Endoscopic Nd-YAG laser therapy as palliative treatment for esophageal and cardial cancer. Parameters affecting long-term outcomeS Naveau, A Chiesa, T Poynard, et al.
The New England Journal of Medicine|December 3, 1981
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled studyD Lebrec, T Poynard, P Hillon, et al.
Hepatology (Baltimore, Md.)|April 27, 1999
Modeling the hepatitis C virus epidemic in FranceS Deuffic, L Buffat, T Poynard, et al.
Age and Ageing|July 1, 1994
A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjectsP Brocker, B Vellas, J L Albarede, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1994
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndromeT Poynard, S Naveau, B Mory, et al.
Gastroenterologie Clinique Et Biologique|June 1, 1986
Sensitivity, specificity and predictive values of the secretin infusion test in the diagnosis of gastrinomaT Poynard, M Mignon, J P Accary, et al.
Pageof 33